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Medicine has greatly improved over the last several decades due to research and 
advances in technology. The quality of life for humans and animals has greatly increased 
due to the ability of doctors to treat more diseases and injuries than previously possible. A 
relatively new area in medicine that is still being researched is the use of stem cells to 
stimulate growth in certain areas of the body. Given the chance, this method of 
regenerative medicine could make a significant difference in how certain injuries are 
treated. A specific injury that is using stem cells is the superficial digital flexor tendon 
(SDFT) in horses. The superficial digital flexor tendon connects to the flexor muscles at the 
carpus region and runs to the area between the proximal and medial phalanx (Marfe et al., 
2012). It is the most plantar structure in the 
metacarpus and metatarsal bone areas, sitting just 
behind the deep digital flexor tendon. Both the 
superficial and deep digital flexor tendons 
comprise the tendon sheath near the metacarpo-
phalangeal joint and the proximal sesamoid bones 
(Marfe et al., 2012).   
The collagen fibers in a tendon run parallel 
to each other, so the SDFT injury disrupts this 
arrangement and forms a lesion in the tendon 
fibers. The lesion will heal naturally by fibrosis, 
but the collagen fibers are smaller and have less 
crosslinks in the tendon, which affects the 
Fig 1. Image of the superficial digital 
flexor tendon in the equine leg. (Thal, 
2016). 
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functionality of the tendon (Guercio et al., 2015). Tendons are a type 1 collagen, which is 
one of the most common connective tissues. The collagen fibrils are composed of three 
polypeptide chains, which are then arranged in a triple helix called tropocollagen (Depalle 
et al., 2015). The tropocollagen helices are stabilized by enzymatic crosslinks between 
amino acids in the 
polypeptide chains. 
Enzymatic reactions 
occur to form covalent 
crosslinks; two 
crosslinks are divalent, 
and another reaction 
will create trivalent 
crosslinks (Depalle et al., 2015). The stabilization and strength of the tropocollagen is 
directly proportional to the density of crosslinks in the tissue, which prevent the sliding of 
the fibrils (Sherman et al., 2015). If the fibrils slide too much, they can rupture the 
crosslinks and ultimately break the collagen.  Therefore, a lack in crosslinks can decrease 
the amount of stress that a tendon is able to withstand (Depalle et al., 2015). A SDFT lesion 
that heals with less crosslinks in the fibers leave the tendon weaker than it started, which 
can be detrimental in an athletic horse that puts a lot of stress on their body.  
The scar tissue that forms also decreases the functionality of the tendon by being 
less elastic, which causes tissues around the lesion to compensate and perform above their 
normal standards (Wood, 2006). The compensation by other tissues will increase the risk 
for re-injury and a decline in performance. In addition, the rate of healing is impeded by the 
Fig 2. Image of the 
structure of the tendon, 
including tropocollagen 
as the triple helical 
collagen molecule.  
(Richardson, 2007) 
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lack of blood flow in the tendons, decreased mitotic division, and the absence of cells able 
to specialize into new tissues (Guercio et al., 2015). The repair process includes an 
accumulation of local cells to the lesion to synthesize new tissue, but this ability is limited 
by the mature tendon’s lack of precursor cells that are able to differentiate (Godwin et al., 
2011). The strength of the collagen fibers is also affected by the hydration of the collagen. 
When water is present in collagen, bonds will form between the collagen and water and 
allow more movement in the fibrils (Sherman et al., 2015). In a dehydrated tendon, bonds 
will instead form directly between fibers and limit the flexible sliding of the collagen. 
Without the vasculature that provides water to the body, the tendons are also at a greater 
risk for forming less water bonds and stiffening the tendon (Sherman et al., 2015). The 
shortage of growth factors in the tendon limits the repair process and the amount of 
regeneration that can occur on its own.  
The SDFT injury typically results from a strain on the tendon that causes 
hyperextension of the metacarpophalangeal joint during activity, and is directly related to 
force on the limb (Godwin et al., 2011).  The force on the limb increases with speed, which 
is also why SDFT injuries are especially prevalent in horses that are engaged in heavy 
training and competition. It is also thought that degeneration of the extracellular matrix 
contributes to SDFT injuries (Godwin et al., 2011). SDFT injuries are one of the most 
common causes of lameness horses at an estimated 30% of all injuries, have long 
rehabilitation periods, and have a high reoccurrence (Iacono et al., 2015). The frequency of 
this injury makes it a significant injury that cannot always be completely healed with 
conventional therapies. Conventional methods of rehabilitation have been successful in 
some horses, but other horses have had to end their athletic careers due to relapse or 
IMPROVEMENTS MADE WITH STEM CELL THERAPY 5 
inability to fully recover from their injury (Marfe et al., 2012). Conventional methods of 
therapy include rest, cold therapy, surgery, anti-inflammatory drugs, steroid joint 
injections, and more (Wood, 2006). Of the 20-60 percent of horses that are able to return to 
their previous levels of athletic ability after conventional therapy, about 80% of those 
horses are susceptible to re-injury.  
 With the location of the SDFT injury and the factors involved, the long length of 
rehabilitation and rate of re-injury are common. Since it is such a prevalent injury in 
athletic horses, methods have been developed to aid in the healing process. One of the 
newer therapies still being explored is the use of stem cell therapy. In this specific injury, 
mesenchymal stem cells (MSCs) are being used to increase efficiency of regeneration 
(Guercio et al., 2015). These stem cells can be extracted from bone marrow and adipose 
tissue and then administered in areas with tissue damage to stimulate the healing of the 
lesion in the tendon. The stem cells are multipotent, which means that they can 
differentiate by dividing and developing into specialized adult cells (Iacono et al., 2015). 
The ability of these cells makes it possible for them to heal the injury by essentially making 
new tissue that is comparable to healthy tissue (Guercio et al., 2015). The stem cells 
minimize the development of scar tissue by providing healthy tissue, whose permanent 
tissue regeneration has provided improved results compared to conventional methods.  
One case study was performed to test the intralesional injection of stem cells in 
horses that have ligament and tendon injuries. Although only one third of the 98 horses 
tested had the superficial digital flexor tendon injury, the other two thirds that were 
suspensory ligament lesions will still show a correlation to the stem cell therapy upon 
connective tissue (Burk and Brehm, 2011). All of the horses were injected with bone 
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marrow stem cells and were tested with follow up exams for more than 12 months. 
Information for only 58 horses could be found for follow up exams, so data was analyzed 
based on the horses and information available. For the treatment to be considered a 
success, the horse needed to return to their original use or previous training ability without 
injury. After 12 months, there was an 84.5% success rate for horses returning to the 
previous abilities, with zero significance in success rate differences between the SDFT and 
suspensory ligament (Burk and Brehm, 2011). Horses that had their injury previously did 
not show as improved return rates, with only 50% returning compared to the average 85% 
from one time injuries. In addition, this study found that the age of the horse could 
influence the success rate of the treatment. Horses under the age of 12 years old had an 
88.9% return, while older horses had a decreased return of 75% (Burk and Brehm, 2011).   
The discipline of the horse was also found to be significant. Horses that participated in 
competitions were only reinjured with a 10% rate, but more intensive flat and trotting 
racehorses had higher reinjury rates of 30 to 66% (Burk and Brehm, 2011). Overall, the 
study showed that not only was the stem cell therapy successful and had higher success 
rates, but that there were differences in the recovery due to the background of the horse.  
Some stem cell studies have shown slight differences in the cultures of two types of 
stem cells, but not necessarily the healing ability of the stem cells. In a study with 
racehorses that had suffered a superficial flexor tendon injury, they researched stem cells 
from equine adipose tissue (fat tissue) at the base of the tail and the other from bone 
marrow in the iliac crest. The horses qualified for the study by undergoing an ultrasound 
that confirmed their injury lesion was a grade 2 and less than 15 days old (Iacono et al., 
2015). The stem cell samples taken from each horse were cultured, and osteogenesis, 
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chondrogenesis, and 
adipogenesis differentiation 
were all confirmed in staining 
procedures. Five racehorses 
were treated with the blood 
marrow stem cells, and the 
other five horses were 
treated with the adipose 
tissue stem cells. The 
animals were put into a 
standard recovery program, and the injury site was checked to record the progress of the 
lesion. By day 30 after implantation, the tendon tissue had nearly been completely 
reformed and the fibers resembled healthy tendon alignment. After 12 months the lesion 
was completely healed and the fibers were aligned as a healthy tendon would be (Iacono et 
al., 2015).  Although all the horses returned to racing, the equine adipose tissue stem cells 
showed better adipogenic and chondrogenic differentiaton, as well as higher cell growth 
(Iacono et al., 2015). For this reason, adipose tissue stem cells could be considered 
advantageous to use in regards to cell banking and culturing the cells, but both types of 
stem cells were effective in returning the horses to their athletic career. 
Adipose tissue and bone marrow stem cells are typically the two stem cells most 
used and researched in this type of injury. Both are multipotent and allow the stem cells to 
differentiate to fat, bone, and cartilage cells (Wood, 2006). However, there are advantages 
to each type of stem cell. Adipose mesenchymal stem cells are arguably more accessible 
Fig 3. Longitudinal and transversal ultrasound images of an injured tendon 
(A) treated with bone marrow stem cells at 30 days (B) and 1 year (C). 
(Iacono et al., 2015) 
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than bone marrow stem cells, especially in equine. Adipose stem cells will usually be taken 
from the gluteal region (Guercio et al., 2015), whereas a bone marrow stem cell sample is 
more invasive and requires a small procedure, such as a sample from the sternebrae or iliac 
crest. Stem cells from adipose tissue have showed a higher adipogenic specialization due to 
their ability to form more lipid vacuoles, and a higher chondrogenic differentiation shown 
by more glycosaminoglycans (Iacono et al., 2015). Due to the accessibility and 
differentiation of the adipose tissue stem cells, it may be more beneficial to use adipose 
stem cells in comparison to bone marrow stem cells, although there shows no difference in 
results. 
In one study, 113 horses from Flat racing or National Hunt racing were injured and 
implanted at the injury site with cultured bone 
marrow stem cells. The stem cells were taken from 
the sternebrae and cultured to attain a higher 
concentration of stem cells in the sample (Godwin 
et al., 2011). The stem cells were injected into the 
lesion site, and a 42 week rehabilitation program 
started immediately following treatment. Although 
the recovery program was not regulated, 111 
horses returned to racing and only 31 horses were 
reinjured on the same limb within three years of 
the treatment. With a 98.2 percent return rate to 
racing and a 27.4 percent re-injury rate, the stem 
Fig 4. Ultrasound of a tendon treated with 
bone marrow stem cells. Godwin et al., 
2011). 
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cell therapy was determined to be more effective than medical management practices by 
nearly halving the re-injury rate (Godwin et al., 2011). The amount of time between injury 
and implantation was also studied and showed results that may be consistent with the 
healing process, but will need a larger sample size in order to be statistically significant. 
The longer the period of time between injury and implantation could directly affect the 
amount of scar tissue that forms, which would affect the effectiveness of the stem cell 
therapy (Godwin et al., 2011). Although the results were not statistically significant, the 
percentage of re-injury rates increased by 15% as the length of time increased by an 
average of 3 weeks (Godwin et al., 2011). Ultimately, bone marrow stem cell therapy shows 
much better return and lower re-injury rates than conventional therapy would in flat and 
National Hunt racehorses.  
A different case study was done on 168 racehorses that had superficial digital flexor 
tendon injuries. These horses were injected with bone marrow MSCs that had been culture 
expanded to obtain a greater number of stem cells. Of the 168 horses tested, 78 percent of 
the horses had no injury for more than one year after treatment. In conventional therapy 
treatments, typically only 44 percent of the horses recover from their injuries for more 
than a year (King, 2015). In addition, the 13 percent re-injury rate of horses with the stem 
cell treatment far surpasses the 56 percent re-injury rate of horses with conventional 
therapies (King, 2015). This statistic also shows that the new tendon tissue from the stem 
cells is better fit for normal activity than the scar tissue that develops without stem cells. 
The stem cells not only have the ability to return the tissue to the same structure, function, 
and tensile strength after regeneration, but also have immunomodulatory paracrine effects 
(King, 2015). Therefore, the stem cell therapy shows great improvement over other 
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methods that may try and mechanically repair the tendons because it more closely 
resembles the normal tissue. 
Immunomodulatory paracrine effects include the stem cells ability to influence the 
immune system. Depending on the conditions of which the stem cells are exposed to, they 
can regenerate, sustain function, and help cell survival (Fontaine et al., 2016). The ability of 
the stem cells to do this is mainly due to the secretion of biological factors that have a 
paracrine effect. These factors include the transforming growth factor (TGF-B1), insulin-
like growth factor, vascular endothelial growth factor (VEGF), and others (Fontaine et al., 
2016). These factors promote reproduction, healing, and the development of new blood 
vessels, which have made stem cells a possible way to treat inflammatory and degenerative 
diseases (Wood, 2006). The stem cells affect the immune system when the secretion of the 
biological factors come in contact with dentritic cells, lymphatic T cells, monocytes and 
macrophages (Fontaine et al., 2016). This process is not completely understood, but clinical 
studies and other tests have been able to link stem cells with these effects on the immune 
system.  
Another stem cell study was done on nine athletic horses that had sustained a 
superficial digital flexor tendon lesion in the foreleg. Each horse showed symptoms 
including pain, swelling, and edema along the tendon, and tendon lesions were confirmed 
by ultrasound. Mesenchymal stem cells from adipose tissue were used due to their 
accessability, isolation procedure, and ability to increase the concentration of MSC’s in vitro 
(Guercio et al., 2015). In addition, platelet-rich plasma (PRP) from the jugular vein was 
injected with the stem cells to increase collagen type 1 production, multiplication, and 
vascularization of the injury site (Guercio et al., 2015). Since the tendon does not get as 
IMPROVEMENTS MADE WITH STEM CELL THERAPY 11 
much blood flow, the PRP mimics blood and its growth factors. The combination of the 
PRPs and the MSCs used on each horse had the same concentration and was injected into 
the lesion site of each injury. The goal of this therapy was to increase the regenerative 
ability of the injury site and return the horses back to their previous level of athletic 
activity (Guercio et al., 2015). 
For the next six months, the horses were subjected to physical therapy and 
increased conditioning until they returned to their careers. The lesion started at a grade 3 
at the time of injury, and had already decreased to a grade two after one month. The grades 
by Reef are an indication of the fiber alignment, with one being the best condition. At two 
months, the tendon fibers showed improvement at a grade 1 and a decreased lesion size. At 
four months, the tendon fibers were completely realigned (Guercio et al., 2015). Of the nine 
athletic horses, seven of them returned to previous levels of activity after seven to nine 
total months of therapy and have not relapsed (Guercio et al., 2015). Two of the horses did 
relapse, but both cases were unrelated to the treated injury. One occurred on a different 
location on the tendon than the original injury, while the other most likely relapsed 
because the owners did not follow the recommended recovery period. The results of the 
therapy also showed that the new tissue closely resembled the tissue size and alignment of 
normal, healthy tissue (Guercio et al., 2015). The healing mechanism of the stem cells 
greatly improves the chances that the horses are able to return to normal athletic abilities 
without a relapse in the SDFT.  
The platelet rich plasma that was used in this study is also another type of 
regenerative medicine that can be paired with stem cells during therapy. PRP has several 
important growth factors and two to four times the amount of platelets as normal blood 
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(Textor, 2011), which help supplies the area with factors that the tendon would be 
deprived of due to lack of blood. The growth factors include platelet-derived growth factor 
(PDGF), transforming growth factor beta (TGF-B1), insulin-like growth factor, and vascular 
endothelial growth factor (VEGF) (Hamilton, 2015). Together, these growth factors 
contribute to increasing the type 3 collagen, increase expression of genes for extracellular 
components and protecting extracellular components by decreasing certain enzyme 
expression (Amable et al., 2013). It is also thought that the PRP may recruit stem cells to 
the injury site, so the combination of extra growth factors and additional stem cells could 
be advantageous to use in junction with stem cell therapy. 
Regenerative medicine and stem cell research have shown that stem cell therapy is a 
highly effective way to manage tendon injuries, one of the most common being the 
superficial digital flexor tendon injury. The ability of the cells to differentiate into several 
types of cells, including muscle and tendon cells, gives the injured tendon the opportunity 
to return to being fully functional. The additional benefits that the stem cells provide to the 
injured tissue include growth factors and immunomodulatory paracrine effects, which help 
with the overall healing process. Stem cell therapy has already been able to improve the 
number of horses able to return to full athletic ability when compared to mechanical or 
surgical methods, regardless of the differences between adipose and blood marrow types 
of stem cells. Although adipose tissue stem cells are more accessible and have been shown 
to differentiate better, blood derived stem cells also provide an effective and successful 
resource for regenerative medicine. Used with other therapies, including platelet rich 
plasma, stem cell therapy is a viable option for horse owners wanting to treat horses that 
are athletically advanced and get better results than those by conventional or surgical 
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methods. If more research is done and approved, stem cell therapy could improve injuries 
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